Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 24.58 USD 2.12% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Nurix Therapeutics Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nurix Therapeutics Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Nurix Therapeutics Inc
NASDAQ:NRIX
Retained Earnings
-$545.2m
CAGR 3-Years
-74%
CAGR 5-Years
-70%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$3.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
$11.2B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$27.1B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-17%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
$7.6B
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$29.4B
CAGR 3-Years
25%
CAGR 5-Years
38%
CAGR 10-Years
84%

See Also

What is Nurix Therapeutics Inc's Retained Earnings?
Retained Earnings
-545.2m USD

Based on the financial report for Nov 30, 2023, Nurix Therapeutics Inc's Retained Earnings amounts to -545.2m USD.

What is Nurix Therapeutics Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-70%

Over the last year, the Retained Earnings growth was -36%. The average annual Retained Earnings growth rates for Nurix Therapeutics Inc have been -74% over the past three years , -70% over the past five years .

Back to Top